Z-1320-2015Class III
cobas EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay
Roche Molecular Systems Inc / initiated 2015-01-13 / Terminated
Roche Molecular Systems, Inc. began a recall of cobas EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay on . FDA classified it as Class III and gives the reason as "False positive results for Exon 20 insertion mutations are being detected with the cobas EGFR Mutation Test, kit batch T08661". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-1320-2015
- Classification
- Class III
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Roche Molecular Systems Inc
- Product
- cobas EGFR Mutation Test epidermal growth factor receptor (EGFR) gene DNA assay
- Product code
- OWD Somatic Gene Mutation Detection System
- Reason for recall
- False positive results for Exon 20 insertion mutations are being detected with the cobas EGFR Mutation Test, kit batch T08661.
- FDA root cause
- Under Investigation by firm
- Action
- RMS notified their customers on 1/13/2015.
- Quantity in commerce
- 190 kits
- Distribution
- Foreign
- Product codes and lots
- T08661
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1320-2015 | Class III | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
